Credit Suisse Ag Castle Biosciences Inc Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Castle Biosciences Inc stock. As of the latest transaction made, Credit Suisse Ag holds 35,809 shares of CSTL stock, worth $761,299. This represents 0.0% of its overall portfolio holdings.

Number of Shares

35,809

Previous 34,050 5.17%

Holding current value

$761,299

Previous $734,000 8.04%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$18.06 - $25.3 $31,767 - $44,502	1,759 Added 5.17%	35,809 $793,000
Q4 2023 Feb 08, 2024	BUY	$12.19 - $22.43 $56,049 - $103,133	4,598 Added 15.61%	34,050 $734,000
Q3 2023 Nov 13, 2023	SELL	$13.28 - $20.3 $19,415 - $29,678	-1,462 Reduced 4.73%	29,452 $497,000
Q2 2023 Aug 11, 2023	BUY	$11.66 - $26.0 $36,425 - $81,224	3,124 Added 11.24%	30,914 $424,000
Q1 2023 May 10, 2023	BUY	$19.47 - $28.49 $89,912 - $131,566	4,618 Added 19.93%	27,790 $631,000

Q4 2022 Feb 13, 2023	BUY	$18.08 - $30.0 $130,772 - $216,990	7,233 Added 45.38%	23,172 $545,000
Q3 2022 Nov 10, 2022	BUY	$22.51 - $34.32 $6,212 - $9,472	276 Added 1.76%	15,939 $416,000
Q2 2022 Aug 12, 2022	BUY	$16.0 - $45.99 $12,784 - $36,746	799 Added 5.38%	15,663 $345,000
Q1 2022 May 16, 2022	BUY	$33.17 - $46.98 $56,588 - $80,147	1,706 Added 12.97%	14,864 $667,000
Q4 2021 Feb 14, 2022	BUY	$39.06 - $67.58 $14,256 - $24,666	365 Added 2.85%	13,158 $564,000
Q3 2021 Nov 12, 2021	BUY	$60.13 - $77.6 $47,983 - $61,924	798 Added 6.65%	12,793 $851,000
Q2 2021 Aug 16, 2021	SELL	$50.07 - $76.78 $29,491 - $45,223	-589 Reduced 4.68%	11,995 $879,000
Q1 2021 May 14, 2021	BUY	$58.92 - $97.33 $18,500 - $30,561	314 Added 2.56%	12,584 $862,000
Q4 2020 Feb 12, 2021	BUY	$43.6 - $73.05 $128,881 - $215,935	2,956 Added 31.74%	12,270 $823,000
Q3 2020 Nov 13, 2020	BUY	$38.47 - $52.03 $358,309 - $484,607	9,314 New	9,314 $479,000

Others Institutions Holding CSTL

# of Institutions

162

Shares Held

25.3M

Call Options Held

82.2K

Put Options Held

150K

View Full List

About CASTLE BIOSCIENCES INC

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $559M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

More about CSTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account